Menu

The 19th Annual
Peptide Therapeutics
Symposium

October 22-23, 2024
Scripps Seaside Forum

Sponsors

Program

The 18th Annual Peptide Therapeutics Symposium was held in a hybrid format on October 16-17, 2023. Registrants were granted access to recorded presentations following the close of the meeting. Posters were available for viewing both in person and virtually. Below please find details from the 2023 Symposium. The 2024 Program will be announced in the coming months.

18th Annual Peptide Therapeutics Symposium
October 16 – 17, 2023
Scripps Seaside Forum, La Jolla, CA
Monday, October 16, 2023
8:00am - 4:00pmRegistration Check-in
The Scripps Seaside Forum Lobby
8:00am - 8:30amBreakfast
The Scripps Seaside Forum Lobby
8:30am - 4:45pm18th Annual Peptide Therapeutics Symposium
Samuel H. Scripps Auditorium
8:30am - 8:35amOpening Remarks
Adam Mezo, Ph.D.
President, Peptide Therapeutics Foundation
Executive Scientific Director, Discovery Biology Research Neurocrine Biosciences, Inc.
8:35am - 10:05amPlenary Lectures
Moderator: Sepideh Afshar
Senior Director and Peptide Discovery Group Leader
Eli Lilly and Company
8:35am - 9:20amPeptide Therapeutics for the Treatment of Obesity and Type 2 Diabetes
Ruth E. Gimeno, Ph.D.
Group Vice President, Diabetes, Obesity and Cardiometabolic Research
Eli Lilly and Company
9:20am - 10:05amAmylin: State of the Union
Thomas Lutz, Ph.D.
Professor in Veterinary Physiology, Institute of Veterinary Physiology, Vetsuisse Faculty
University of Zurich
10:05am - 10:35amBeverage Break & Poster Viewing
The Scripps Seaside Forum Lobby
10:35am - 12:05pmSession I
Moderator: Bryan Fuchs, Ph.D.
Vice President, Gastroenterology
Ferring Pharmaceuticals
10:35am - 11:05amHarnessing the Power of Molecular Imaging for Precision Medicine: Radiolabeled Peptides, Antibodies, and Everything in Between
Weibo Cai, Ph.D.
Vilas Distinguished Achievement Professor of Radiology, Medical Physics, Materials Science & Engineering, Pharmaceutical Sciences
University of Wisconsin - Madison
11:05am - 11:35amRadionuclide Theranostics: Current State and Future Perspectives
Ken Herrmann, MD, MBA
Department Chair, Nuclear Medicine
Universitätsklinikum Essen, Germany
11:35am - 12:05pmEstablishing a Novel Platform for Discovery of CPPs that Localize in Cytoplasm
Jinsha Liu, Ph.D.
Advisor
Eli Lilly and Company
12:05pm - 1:05pmLunch & Poster Viewing
The Scripps Seaside Forum Lawn
1:05pm - 2:35pmSession II
Moderator: Antoine Henninot
Director
Takeda Pharmaceuticals
1:05pm - 1:35pmDevelopment of Efruxifermin, an FGF21 Analog, for Treatment of Nonalcoholic Steatohepatitis (NASH)
Jonathan M. Young, Ph.D., J.D.
Co-Founder and Chief Operating Officer
Akero Therapeutics, Inc.
1:35pm - 2:05pmSafe and Effective Delivery of Nucleic Acids Using Proteolipid Vehicles Formulated with Fusion-Associated Small Transmembrane Proteins
John D. Lewis, Ph.D.
Founder & CEO
Entos Pharmaceuticals
2:05pm - 2:35pmStealth Editing™ - A Novel Non-Immunogenic In Vivo Gene Editing Technology
Dietrich A. Stephan, Ph.D.
Founder & CEO
NeuBase Therapeutics
2:35pm– 2:55pmBeverage Break & Poster Viewing
The Scripps Seaside Forum Lobby
2:55pm - 4:25pmSession III
Moderator: Ron He, PhD, MBA
Principal Scientist
Peptide Chemistry | Discovery Biologics
Neurocrine Biosciences, Inc
2:55pm - 3:25pmNeuregulin 4 (NRG4) as a New Hormonal Therapy for NASH-related Liver Cancer
Jiandie Lin, Ph.D.
Bradley M. Patten Collegiate Professor of Life Sciences, Professor of Cell & Developmental Biology, Research Professor in the Life Sciences Institute
University of Michigan
3:25pm - 3:55pmActivation of the Insulin Receptor by Insulin and Non-insulin Peptide: Application in Human Disease
Eunhee Choi, Ph.D.
Assistant Professor, Department of Pathology and Cell Biology Columbia University
3:55pm - 4:25pmThe Structure-function of the Endocrine FGFs: Nature Repeats Itself
Archita Agrawal, Ph.D.
Postdoctoral Researcher
Salk Institute for Biological Studies
4:25pm - 4:45pmTribute to Waleed Danho
4:45pm - 6:15pmOpening Reception
The Scripps Seaside Forum Lawn
Tuesday, October 17, 2023
8:00am - 10:00amRegistration Check-in
The Scripps Seaside Forum Lobby
8:00am - 8:30amBreakfast
The Scripps Seaside Forum Lobby
8:30am - 12:30pm18th Annual Peptide Therapeutics Symposium
Samuel H. Scripps Auditorium
8:30am - 8:45amWelcoming Remarks
Phil Dawson, Ph.D.
Chairman of the Board, Peptide Therapeutics Foundation
Professor of Chemistry, Scripps Research
Dean of the Skaggs Graduate School of Chemistry and Biological Sciences
8:45am - 10:15amPlenary Lectures
Moderator: David Parkes
President
DGP Scientific Inc.

8:45am - 9:30amThe Interplay of Insulin and Glucagon: From Physiology to Pharmacology
David Maggs, MD, FRCP
Abvance Therapeutics
UT Health San Antonio TX
9:30am - 10:15amOne Ellipsoid to Rule Them All — Cathelicidin-mimicking Peptoids that are Antiviral, Antibacterial & Antifungal and Well-tolerated in the Airways
Annelise E. Barron, Ph.D.
Associate Professor of Bioengineering
Stanford University, Schools of Medicine and Engineering
10:15am - 10:45amBeverage Break & Poster Viewing
The Scripps Seaside Forum Lobby
10:45am - 12:15pmSession IV
Moderator: Robert Hagopian
Director, Peptide Therapeutics Foundation
Director, Business Development, Group Pipeline
PolyPeptide

10:45am - 11:15amComputational Design of Novel Peptides for SORT1 and Their Use in Oncology
Lucas Siow
Co-Founder & CEO
ProteinQure Inc.
11:15am - 11:45amPegcetacoplan: the CMC Journey through Development to FDA Approval
Christopher P Holmes, Ph.D.
VP of Chemical and Pharmaceutical Development
Apellis
11:45am - 12:15pmAdvances in Oligonucleotide Delivery to Muscle Using Antibody Oligonucleotide Conjugates (AOCs): Transferrin Receptor 1 (TfR1) Mediated Uptake of AOCs for the Treatment of Muscular Dystrophies
Arthur A. Levin
Avidity Board Member
Distinguished Scientist & Strategic Leader
Avidity Biosciences

12:15pm - 12:30pmClosing Remarks
Nick Cox, Ph.D.
Director, Peptide Therapeutics Foundation
Associate Director of Discovery Chemistry, Novo Nordisk
12:30pm - 1:30pmNetworking Lunch
The Scripps Seaside Forum Lawn
News
Symposium

 

Sponsors